Gloria Lena Vega
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gloria Lena Vega has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Scott M. Grundy
UT Southwestern Medical Center
16 shared publications Scott M. Grundy
Departments of Clinical Nutrition and Internal Medicine, Center for Human Nutrition of the University of Texas Southwestern Medical Center, Dallas, TX, USA; The Veterans Administration North Texas Health Care System, Dallas, TX, USA
6 shared publications- Myron F. Weiner
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
4 shared publications Jijia Wang
Applied Clinical Research, University of Texas Southwestern Medical Center
3 shared publicationsAslan T. Turer
University of Texas Southwestern Medical Center
2 shared publicationsCarol Moore
Univ Texas Dallas, SW Med Ctr, Alzheimers Dis Ctr, Dallas, TX 75390 USA
2 shared publications
Latest Publications
- Open Access
- 1 January 2022
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 16 (1) , 66-74
Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease
- 1 January 2022
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 16 (1) , 66-74
Open AccessPrevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease
- Open Access
- 8 July 2021
- Published by Elsevier in Toxicology
- Vol. 459, 152845
Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? A workshop report on potential mechanisms
- 8 July 2021
- Published by Elsevier in Toxicology
- Vol. 459, 152845
Open AccessWhy is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? A workshop report on potential mechanisms
- Open Access
- 1 March 2021
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 15 (2) , 255-265
Utility of metabolic syndrome as a risk enhancing factor in decision of statin use
- 1 March 2021
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 15 (2) , 255-265
Open AccessUtility of metabolic syndrome as a risk enhancing factor in decision of statin use
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 15 (1) , 173-180
Chronic kidney disease and statin eligibility
- 1 January 2021
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 15 (1) , 173-180
Open AccessChronic kidney disease and statin eligibility
- Open Access
- 1 July 2020
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 14 (4) , 425-430
Temporal decline in non–high-density lipoprotein cholesterol in subjects with diabetes mellitus without atherosclerotic cardiovascular disease
- 1 July 2020
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 14 (4) , 425-430
Open AccessTemporal decline in non–high-density lipoprotein cholesterol in subjects with diabetes mellitus without atherosclerotic cardiovascular disease
- Open Access
- 1 July 2019
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 13 (4) , 563-567
Current trends in non–HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease
- 1 July 2019
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 13 (4) , 563-567
Open AccessCurrent trends in non–HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease
- Open Access
- 2 November 2017
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 1 (12) , 1417-1427
Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome
Context Polycystic ovarian syndrome (PCOS) is often associated with obesity and diabetes. Objective The present study measured body fat distribution and metabolic risk factors in women with features of PCOS. Design Cross-sectional, multiethnic study of cardiovascular risks. Setting General community. Study Participants 145 PCOS and 344 non-PCOS women. Exposure Measures Body composition by dual x-ray absorptiometry; abdominal fat masses measured by magnetic resonance imaging and hepatic triglyceride by magnetic resonance spectroscopy. Outcomes Measures Body composition, liver fat content, homeostatic model assessment for insulin resistance (HOMA-IR), revised, and metabolic syndrome components. Results PCOS women had a higher free androgen index compared with the non-PCOS women. Nonobese PCOS and non-PCOS women had a similar body fat content and distribution, HOMA-IR, and hepatic triglyceride content. Obese PCOS women had a similar total body fat percentage compared with their non-PCOS counterparts (41.4% and 41.4% respectively). Both obese groups had similar intraperitoneal fat (1.4% of total body mass in PCOS vs 1.4% in non-PCOS). However, obese PCOS women had a greater ratio of truncal/lower body fat (1.42 vs 1.27; P < 0.016). They also had greater insulin resistance (HOMA-IR: PCOS, 2.24% vs non-PCOS, 1.91%; P < 0.016), higher liver triglyceride content (6.96% in PCOS vs 4.44% in non-PCOS; P < 0.016), and a greater incidence of hypertension (33% vs 24%; P < 0.05). No differences were observed in other metabolic risk factors. Conclusions Both obese and nonobese women with PCOS features had a greater free androgen index compared with non-PCOS women, but neither had greater intraperitoneal fat or abnormal lipid levels. Obese, but not nonobese, women with PCOS had a greater truncal/lower extremity fat ratio, HOMA-IR, and liver triglyceride content.
- 2 November 2017
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 1 (12) , 1417-1427
Open AccessMetabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome
Context Polycystic ovarian syndrome (PCOS) is often associated with obesity and diabetes. Objective The present study measured body fat distribution and metabolic risk factors in women with features of PCOS. Design Cross-sectional, multiethnic study of cardiovascular risks. Setting General community. Study Participants 145 PCOS and 344 non-PCOS women. Exposure Measures Body composition by dual x-ray absorptiometry; abdominal fat masses measured by magnetic resonance imaging and hepatic triglyceride by magnetic resonance spectroscopy. Outcomes Measures Body composition, liver fat content, homeostatic model assessment for insulin resistance (HOMA-IR), revised, and metabolic syndrome components. Results PCOS women had a higher free androgen index compared with the non-PCOS women. Nonobese PCOS and non-PCOS women had a similar body fat content and distribution, HOMA-IR, and hepatic triglyceride content. Obese PCOS women had a similar total body fat percentage compared with their non-PCOS counterparts (41.4% and 41.4% respectively). Both obese groups had similar intraperitoneal fat (1.4% of total body mass in PCOS vs 1.4% in non-PCOS). However, obese PCOS women had a greater ratio of truncal/lower body fat (1.42 vs 1.27; P < 0.016). They also had greater insulin resistance (HOMA-IR: PCOS, 2.24% vs non-PCOS, 1.91%; P < 0.016), higher liver triglyceride content (6.96% in PCOS vs 4.44% in non-PCOS; P < 0.016), and a greater incidence of hypertension (33% vs 24%; P < 0.05). No differences were observed in other metabolic risk factors. Conclusions Both obese and nonobese women with PCOS features had a greater free androgen index compared with non-PCOS women, but neither had greater intraperitoneal fat or abnormal lipid levels. Obese, but not nonobese, women with PCOS had a greater truncal/lower extremity fat ratio, HOMA-IR, and liver triglyceride content.
- Open Access
- 1 November 2016
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 10 (6) , 1414-1422.e1
Association of triglyceride-to-high density lipoprotein cholesterol ratio to cardiorespiratory fitness in men
- 1 November 2016
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 10 (6) , 1414-1422.e1
Open AccessAssociation of triglyceride-to-high density lipoprotein cholesterol ratio to cardiorespiratory fitness in men
- Open Access
- 18 July 2016
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 6 (7) , e221
Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study
Background/Objectives: Visceral adipose tissue (VAT) mass, a risk factor for cardiometabolic complications of obesity, is usually measured by magnetic resonance imaging (MRI) but this method is not practical in a clinical setting. In contrast, measurement of VAT by dual-x-ray absorptiometry (DXA) appears to circumvent the limitations of MRI. In this study, we compared measurements of VAT mass by MRI and DXA in the large, multiethnic cohort of the Dallas Heart Study (DHS). Subjects/Methods: About 2689 DHS participants underwent paired measurement of VAT by MRI and DXA. Sex-stratified analyses were performed to evaluate the correlation and agreement between DXA and MRI. Model validation was performed using bootstrapping and inter-reader variability was assessed. Results: Mean age of the cohort was 44 years, with 55% female, 48% Black and 75% overweight/obese participants. Regression analysis showed a linear relationship between DXA and MRI with R2=0.82 (95% confidence interval (CI) 0.81–0.84) for females and R2=0.86 (95% CI 0.85–0.88) for males. Mean difference between methods was 0.01 kg for females and 0.09 kg for males. Bland–Altman analysis showed that DXA tended to modestly underestimate VAT compared with MRI at lower VAT levels and overestimate it compared with MRI at higher VAT levels. Results were consistent in analyses stratified by race, body mass index status, waist girth and body fat. Inter-individual reader correlation among 50 randomly selected scans was excellent (inter-class correlation coefficient=0.997). Conclusions: VAT mass quantification by DXA was both accurate and valid among a large, multiethnic cohort within a wide range of body fatness. Further studies including repeat assessments over time will help determine its long-term applicability.
- 18 July 2016
- Published by Springer Nature in Nutrition & Diabetes
- Vol. 6 (7) , e221
Open AccessComparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study
Background/Objectives: Visceral adipose tissue (VAT) mass, a risk factor for cardiometabolic complications of obesity, is usually measured by magnetic resonance imaging (MRI) but this method is not practical in a clinical setting. In contrast, measurement of VAT by dual-x-ray absorptiometry (DXA) appears to circumvent the limitations of MRI. In this study, we compared measurements of VAT mass by MRI and DXA in the large, multiethnic cohort of the Dallas Heart Study (DHS). Subjects/Methods: About 2689 DHS participants underwent paired measurement of VAT by MRI and DXA. Sex-stratified analyses were performed to evaluate the correlation and agreement between DXA and MRI. Model validation was performed using bootstrapping and inter-reader variability was assessed. Results: Mean age of the cohort was 44 years, with 55% female, 48% Black and 75% overweight/obese participants. Regression analysis showed a linear relationship between DXA and MRI with R2=0.82 (95% confidence interval (CI) 0.81–0.84) for females and R2=0.86 (95% CI 0.85–0.88) for males. Mean difference between methods was 0.01 kg for females and 0.09 kg for males. Bland–Altman analysis showed that DXA tended to modestly underestimate VAT compared with MRI at lower VAT levels and overestimate it compared with MRI at higher VAT levels. Results were consistent in analyses stratified by race, body mass index status, waist girth and body fat. Inter-individual reader correlation among 50 randomly selected scans was excellent (inter-class correlation coefficient=0.997). Conclusions: VAT mass quantification by DXA was both accurate and valid among a large, multiethnic cohort within a wide range of body fatness. Further studies including repeat assessments over time will help determine its long-term applicability.
- Open Access
- 1 March 2016
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 10 (2) , 283-288
Fatty acid oxidation in normotriglyceridemic men
- 1 March 2016
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 10 (2) , 283-288
Open AccessFatty acid oxidation in normotriglyceridemic men